SAN FRANCISCO, Oct. 28, 2024 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that the results of the Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk […]
Tag: iRhythm
AFIB: A SILENT CAUSE OF HEART FAILURE AND STROKE
*** September is National Atrial Fibrillation Awareness Month *** SAN FRANCISCO, Sept. 17, 2024 /PRNewswire/ — BACKGROUND: We all know someone who’s had a heart scare – an unusual flutter or disconcerting palpitations. The potential cause? A little-known and often silent heart health…
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor
SAN FRANCISCO, Sept. 26, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the U.S. launch of its next-generation Zio® monitor and enhanced Zio® long-term continuous monitoring (LTCM) service. Zio monitor is iRhythm’s smallest, lightest and thinnest cardiac monitor, enhancing the cardiac monitoring […]
iRhythm Technologies Announces Second Quarter 2023 Financial Results
SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three and six months ended June 30, […]
iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments
SAN FRANCISCO, June 06, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the appointment of Mojdeh Poul and Brian Yoor as directors to […]
New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias
Clinical studies presented at Heart Rhythm 2023 build on the totality of clinical evidence that continue to highlight the value of iRhythm’s Zio products and services across a wide range of patient populations SAN FRANCISCO, May 22, 2023 (GLOBE NEWSWIRE) […]
iRhythm Technologies Announces First Quarter 2023 Financial Results
SAN FRANCISCO, May 04, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today reported financial results for the three months ended March 31, 2023. First […]
iRhythm Technologies Releases 2022 Environmental, Social, and Governance Report Reflecting Strategy to Deliver Purpose-Driven Growth
SAN FRANCISCO, April 12, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, today released its 2022 Environmental, Social, and Governance (“ESG”) Report highlighting the company’s continued […]
Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors
Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of products and services SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, […]
iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results
SAN FRANCISCO, Feb. 23, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended […]